Background: Ulcerative colitis (UC) only involves the colonic mucosa. Yet, nearly 50% of patients with UC who undergo total proctocolectomy with
T he causes of human inflammatory bowel diseases (IBDs) are still unknown although most believe they arise from an unfortunate convergence of genetic, environmental, and microbial factors-each necessary but not sufficient to cause disease. Despite recent advances in medical therapy, approximately 30% of patients with ulcerative colitis (UC) become medically refractory and undergo total proctocolectomy. 1 Creation of an ileal pouch anal anastomosis (IPAA) from disease-free ileum has become the procedure of choice in these patients to preserve continence and intestinal continuity. Although UC does not affect the ileum before surgery, as many as 50% of patients develop a UC-like inflammatory condition (pouchitis) in the pouch within 2 years after surgery. [2] [3] [4] By contrast, patients without IBD with the precancerous disorder familial adenomatous polyposis (FAP) who undergo the same procedure develop pouchitis at a far lower rate (and their pouchitis is clinically different). 5, 6 This observation suggests that the underlying disease predisposition and the mechanisms of pathogenesis that lead to UC in the colon may be replicated within the ileal pouch after the fecal stream is reestablished. Because risk and the onset of IBD cannot be predicted, most studies are performed after diagnosis when many confounding variables (inflammation, medications, surgery, diet) obscure the distinction between causal and consequential events. The human pouchitis model, however, is not encumbered with many of the challenges that have limited IBD research. Patients Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.ibdjournal.org).
with UC with IPAA provide a known, susceptible, and more homogenous population that can be easily sampled and followed prospectively from "time zero" before disease has occurred and therefore act as their own controls.
However, many studies of the UC pouch to date have been cross-sectional and unable to determine whether gene expression changes noted in the ileal pouch are transient or more lasting and related to underlying mechanisms of disease. Studies of the host have suggested that there may be partial colonic metaplasia that occurs in the ileal pouch. [7] [8] [9] Villus shortening and crypt hyperplasia have been described, although histologic changes appear to be patchy and inconsistent. Some have argued that these changes may be secondary to inflammation. 10 Increased sulfomucin production has also been described in the UC pouch, which is more characteristic of the colon, whereas FAP pouches retain a more sialomucin-predominant mucus layer. 11 Few studies have examined the gene expression changes that occur in the UC pouch and FAP pouch that may precede any histologic changes. Ben-Shachar et al 12 examined gene expression as measured by DNA microarray in the UC normal terminal ileum, healthy pouches, chronic pouchitis, and Crohn's-like disease of the pouch. They found that compared to patients with normal pouches, patients with chronic pouchitis and Crohn's like disease of the pouch had far more gene expression changes and changes of higher magnitude as compared to normal UC ileum. However, this study was not focused on examining which host events precede the onset of inflammation but rather which changes correlate with inflammation. Gene arrays by Paziewska et al 13 have demonstrated that there are significant gene expression differences between the UC and FAP pouch, suggesting that there is something unique about the UC pouch that makes it more prone to pouchitis. Kabakchiev et al 14 described downregulation of some transporters and upregulation of inflammatory pathways in the UC ileal pouch as compared with the prepouch ileum that correlates with the outcome of no pouchitis versus pouchitis or Crohn's-like inflammation. Thus, several studies have noted that the UC pouch is unique as compared with the FAP pouch and that the tissue in the ileal pouch undergoes reprogramming that distinguishes it from the ileal tissue immediately above it.
In this study, we examine a homogenous, healthy group of patients with UC from 4 months after their pouch is in continuity. Patients were followed longitudinally to act as their own controls at 8 months and at 12 months post pouch creation. Thus, this is the first pouch cohort to be followed longitudinally to understand which pouch gene expression changes occur early and persist over time. Pouch gene expression was examined by unbiased, highly sensitive RNA sequencing (RNA-seq). We found that the UC pouch transcriptional profile is consistent with colonic metaplasia, changes in the extracellular matrix, enhanced immune activation, and suppressed xenobiotic metabolism and P450 signaling; i.e., changes that may explain why UC only involves the colon and why there is a propensity to develop pouchitis in the UC ileal pouch mucosa. These changes promote disease susceptibility but are not sufficient by themselves to cause pouchitis. Additional environmental and/or microbial triggers are likely needed for the clinical onset of disease.
MATERIALS AND METHODS

Patient Cohort and Sample Collection
Patients were recruited for the prospective Sinai-Helmsley Alliance for Research Excellence study at the University of Chicago Medical Center and Mayo Clinic Rochester. Patients with UC who underwent total proctocolectomy with IPAA and were 18 years of age or older were eligible for the study. Participants underwent pouchoscopy at 4, 8, and 12 months after ileostomy takedown. At each visit, patient data including current medications, smoking status, and clinical symptoms were recorded. Patients with FAP who underwent total proctocolectomy with IPAA were recruited at the Mayo Clinic, Rochester, and underwent a one-time pouchoscopy. None of the FAP patients included in this study are genetically related. The Institutional Review Boards of the University of Chicago and Mayo Clinic approved this study. All study subjects provided informed consent. Total RNA was isolated using the AllPrep DNA/RNA Mini Kit (QIAGEN, Cat No. 8020), and RNA quality and integrity were confirmed by Nanodrop (A260/A280 ratios between 1.7 and 2.2) and Bio-Analyzer mini-gel assay.
RNA-seq Library Preparation and Sequencing
RNA quality was evaluated using the Bioanalyzer (Agilent, Santa Clara, CA). All RNA samples displayed RNA integrity number .7. RNA-seq including cDNA library preparation was processed at the Genomics Core Facility of the University of Chicago (https://fgf.uchicago.edu/). Total RNA in the amount of 100 to 500 mg per sample was depleted of ribosomal RNA using the Ribo-Zero kit (Epicentre, Madison, WI). The directional (firststrand) cDNA libraries were prepared following the guide of TruSeq Stranded Total RNA Sample Preparation kit. RNA was fragmented at 948C for 6 minutes, followed by the first-strand cDNA generation. Deoxyuridine triphosphate was incorporated in second strand synthesis to effectively quench the second strand during PCR amplification. After adenylation of the 3' end and ligation of adapters, fragments were selected and enriched with 10 cycles of PCR amplification. Clusters were generated by bridge amplification within paired-end flow cells using Illumina TruSeq paired-end (PE) Cluster Kit v3-cBot-HS according to manufacturer's instructions (Illumina, San Diego, CA). The clusters on flow cells were then sequenced on the Illumina HiSeq2500 using TruSeq SBS kit v3. A total of 437 Gbase data were generated for cDNA libraries prepared from 72 samples using high output mode of 75-bp PE reads (59 libraries) or 50-bp single-end reads (16 libraries) . Three libraries were sequenced twice with both 50-bp single-end reads and 75-bp PE reads. Around 94.4% sequences passed quality check (.Q30), yielding 2.7 billion passing filter clusters in total or ;40-M passing filter clusters per sample.
RNA-seq Reads Processing and Normalization
Raw data were processed with splice junction mapper Tophat. 15 Briefly, reads in FASTQ format were aligned to the University of California, Santa Cruz, human genome hg19 using Tophat version 2.0.10 incorporated with the Bowtie version 2.1.0. 16 Up to 3 mismatched nucleotides were allowed for the alignment of each read. Transcriptome assembly was performed using the R/Bioconductor package "Rsubread." 17 The aligned .bam files were mapped to the reference transcriptome (University of California, Santa Cruz, known annotation).
The abundance of transcripts was summarized into Reads Per Kilobase of transcript per Million mapped reads. Genes with a value of Reads Per Kilobase of transcript per Million mapped reads .1 in at least one sample were included for downstream analysis using the R/CRAN package "limma". 18 The "voom" normalization implemented in the limma package was applied to transform count data into log2-counts per million with associated precision weights. 19 Between-sample normalization with the "quantile" method implemented in limma was used to reduce noise associated with the clinical samples. The R/Bioconductor package "sva" was used to remove batch effects associated with the 2 library preparations in this study. 19 Specifically, the "ComBat" algorithm implemented in sva was adopted to adjust for batch effects using an empirical Bayes framework. 20 Correction of the batch effect was controlled using the 3 libraries that were sequenced twice using both 50-bp single-end and 75-bp PE reads mode. The raw reads and processed data were deposited in the NCBI Gene Expression Omnibus database with accession number GSE81266 and Sequence Read Archive database with accession number SRP074739.
Differential Expression Profiling
Unsupervised sample classification was performed using multidimensional scaling (MDS) plots. MDS, based on the Euclidean distance between each pair of samples, is an intrinsic function implemented in the R/Bioconductor package limma. 18 Differentially expressed genes (DEGs) were identified using the empirical Bayes-moderated t-test implemented in the R/Bioconductor package limma. 21 The P-values were adjusted for multiple comparisons using the Benjamini-Hochberg method. 22 Differences between pouch and prepouch gene expression were also estimated independently of sample size using Cohen's effect size, which was calculated from 23 The cross-platform comparison of effect size between RNA-seq and Morgan's microarray data was performed by meta-analysis using R/Bioconductor package "GeneMeta." The percentage of significant genes was determined by the z-score of average effect size followed by column-wise permutation within each data set to control the false discovery rate.
Quantitative Reverse Transcription Polymerase Chain Reaction 
Canonical Pathway and Gene Ontology Analysis
Significant canonical pathways or gene interaction networks were analyzed by the Ingenuity Pathway Analysis software (Ingenuity Systems, Redwood City, CA) using one-tailed (referring to the overrepresented pathways) Fisher's exact test with the criterion of Benjamini-Hochberg adjusted P-value ,0.01. Significant biological processes of gene ontology were identified using R/Bioconductor package "GOSim" with criterion of BenjaminiYekutieli adjusted P , 0.005. 24 
Sample Classification and Gene Clustering
Sample and gene clustering based on a priori selected genes was performed using dChip software with the following parameters: distance matrice ¼ "1-correlation" and linkage method ¼ "centroid." 25 Self-organizing map (SOM) extracts the N most prominent patterns (where N is the number of nodes in the geometry) and arranges them so that similar patterns occur as neighbors in the SOM. 26 We used the R package SOM to generate a 2-dimensional SOM with means and standard deviation of the centralized genes at different intestinal locations. The normalized RNA-seq data were further standardized before SOM clustering, so that each row has a mean of 0 and variance of 1.
RESULTS
Demographic and Clinical Characteristics
Seventeen patients with UC and 4 patients with FAP were recruited at the University of Chicago and the Mayo Clinic, Rochester. All patients underwent a total proctocolectomy with IPAA as a standard of care. Patients with UC underwent a pouchoscopy for biopsy of the prepouch ileum and pouch at 4, 8, and 12 months after ileostomy closure (see Fig. S1 , Supplemental Digital Content 1, http://links.lww.com/IBD/ B437). None of these patients had pouchitis, as defined by the pouch disease activity index, during the time of their biopsies. For samples of patients with FAP, a single pouchoscopy with biopsies of the pouch and prepouch ileum was performed; these patients were biopsied at 2 to 8 years after ileostomy closure. Demographic and clinical characteristics are as shown in Table 1 . Pouch tissues were formalin-fixed, stained with hematoxylin and eosin, and assessed for histologic evidence of inflammation as well as colonic metaplasia by a blinded gastrointestinal pathologist. None of the biopsies showed significant metaplasia, characterized by villus shortening and crypt elongation. Clinical data analysis revealed that the proportion of pouchitis development was significantly higher in female than male patients with UC in our small cohort (x 2 P ¼ 0.0133).
The UC Pouch and prepouch Ileum Have Distinct Gene Expression Profiles
To investigate how the transcriptome of the ileal mucosa responds to the creation of an ileal pouch, we performed deep sequencing of RNA (RNA-seq) isolated from pouch and prepouch ileum biopsies in patients with UC and FAP. The prepouch ileum is the ileal segment immediately proximal to the pouch that, even when UC pouchitis develops, is not involved by inflammation, thus serving as an internal control. We first performed unsupervised sample classification of UC pouch and prepouch ileum using MDS analysis. MDS highlighted the differences between the UC pouch and prepouch ileum at 4, 8, or 12 months based on their global transcriptomic profiles ( Fig. 1A -C, respectively) despite the fact that the pouch is created from the same ileal tissue from which prepouch samples were obtained. We further combined all UC pouch and prepouch samples at the 3 time points for MDS, which also demonstrated very distinct differences between the UC pouch and prepouch regions (Fig. 1D) .
We then identified DEGs between all pouch and prepouch ileum samples using the empirical Bayes-moderated t-test implemented in R/Bioconductor package "limma." Among our samples of patients with UC, we found 6521 DEGs between the pouch and prepouch ileum, including 3105 upregulated and 3416 downregulated genes with criterion of adjusted P , 0.1. In this set, 746 DEGs displayed at least a 1.5-fold change, including 378 upregulated and 368 downregulated genes in the pouch. In contrast to the UC pouch, none of the genes in the FAP pouch displayed significant changes when compared with the prepouch ileum with the same criterion of adjusted P , 0.1 (see Fig. S1 , Supplemental Digital Content 1, http://links.lww.com/IBD/B437). Given the rare nature of FAP, we had fewer FAP pouch-derived samples than UC pouch-derived samples. Therefore, we computed the Cohen's effect size to assess the scale of differential gene expression between pouch and prepouch independent of sample size. This analysis indicated that the effect size of the pouch on ileal gene expression is overall greater in patients with UC than in patients with FAP (see Fig. S2A , Supplemental Digital Content 2, http://links.lww.com/IBD/B438). This finding underscores the unique molecular characteristics of the UC pouch.
We compared our RNA-seq data to the previously published microarray data of pouch and prepouch ileum gene expression from 265 patients, including 233 with UC and 32 with FAP. 27 This cross-sectional study compared expression profiles from intestinal biopsies taken .1 year after IPAA and included patients with or without pouchitis. Of the 746 DEGs from our project, 566 genes mapped to the microarray data from Morgan et al. 27 For these 566 overlapping genes, the log2-transformed fold changes of the pouch to prepouch ileum were highly correlated between our data set and the cross-sectional data set of Morgan et al 27 (Fig. 1E) . These findings indicate that the early transcriptomic alterations in our UC pouch cohort are maintained throughout the natural history of the ileal pouch, even after pouchitis develops.
Given the low number of patients with FAP in our study cohort, we performed a meta-analysis including data from our RNA-seq of UC prepouch ileum and pouch samples with the larger cohort of FAP samples (28 prepouch and 18 pouch samples) analyzed via microarray by Morgan et al. Meta-analysis was performed using the R/Bioconductor package GeneMeta. Similar to our RNA-seq FAP samples shown in Figure S2A , this larger cohort of patients with FAP also demonstrated a smaller pouch effect size than our UC cohort when compared by the z-score or percentage of DEGs (see Figs. S2B and S2C, Supplemental Digital Content 2, http://links.lww.com/IBD/B438). Moreover, only 5/46 colonic target markers identified in our UC pouch displayed differential expression (adjusted P , 0.05) between FAP pouch and prepouch ileum in this FAP data, thus indicating a different transcriptomic pattern between the FAP and UC pouch in comparison to the corresponding prepouch ileal tissue. The 378 upregulated and 368 downregulated genes in our UC pouch were uploaded into the Ingenuity Pathway Analysis software to identify significantly enriched canonical pathways (Fig. 2 , and see Tables S2 and S3 , Supplemental Digital Content 3, http://links.lww.com/IBD/B439). Pathway analysis revealed transcriptional activation of the immune/ inflammatory response and tissue remodeling pathways ( Fig. 2A) , along with repression of lipid and xenobiotic metabolism (Fig. 2B ).
Altered barrier function may contribute to the pathogenesis of pouchitis and UC. 28 We found that of the 138 genes in the Kyoto Encyclopedia of Genes and Genomes tight junction pathway, 65 were differentially expressed between the pouch and prepouch ileum in our UC cohort. Within this set of 65 genes, 40 genes were also differentially expressed between the inflamed pouch and uninvolved prepouch ileum mucosa in microarray analysis 27 ; importantly, 39 of these 40 genes displayed similarity in the direction and magnitude of expression change, whether FIGURE 1. UC pouch and prepouch ileum have distinct gene expression profiles. MDS analysis was performed using RNA-seq data from pouch ("pou") and prepouch ("pre") ileum biopsies in patients with UC at 4 (A), 8 (B), or 12 months (C) after ileostomy closure, or all time points combined (D). The MDS plots are shown with samples identified by location (E). Concordance of gene expression changes in the UC pouch over short (,12 months) and long (.12 months) time scales. Each circle on the scatter plot represents a transcript whose expression significantly changes in the UC pouch after ileostomy closure, with distance along the x-axis and y-axis reflecting the log2-transformed magnitude of expression ratio between pouch and prepouch ileum. Values along the x-axis were computed from RNA-seq data in the present study, with criteria of fold-change .1.5 and adjusted P , 0.1. Values along the y-axis were calculated from published microarray data of patients with pouchitis with biopsies collected .1 year after ileostomy closure. 27 pUCD, pouch with UC pouchitis; iUCD, ileum with UC pouchitis.
analyzed by RNA-seq or microarray 27 (see Fig. S3 , Supplemental Digital Content 4, http://links.lww.com/IBD/B440). By contrast, none of the tight junction genes demonstrated significant differences in expression between the pouch and prepouch in patients with FAP in our cohort, in agreement with previous findings. 27 Taken together, these data strongly suggest that changes in the expression of tight junction genes are a common feature of the ileal pouch in patients with UC. These data support the idea that intestinal barrier dysfunction contributes to IBD risk. 28 The UC Pouch Develops a Colonlike Transcriptome
We next examined whether the alterations in the pouch transcriptome in patients with UC represented a shift to a more "colon-like" gene expression profile. DEGs between pouch and prepouch identified by RNA-seq (this study) or microarray 27 were compared with DEGs (fold change . 2 and adjusted P , 0.05) in microarray expression data for healthy human colon and ileum. 29 A majority of the genes upregulated in the UC pouch were also expressed at significantly higher levels in the colon than in the ileum, whereas the opposite tended to be true of downregulated pouch genes (Fig. 3A-C) . This correlation held true regardless of the disease state (pouchitis or no pouchitis) or method of transcriptome assay (microarray versus RNA-seq). Taken together, these data confirm that the ileal pouch develops molecular features characteristic of colonic mucosa very early after IPAA, in the absence of visible histological changes. We hypothesize from our data that specific genes and pathway responses unique to colonic tissue render subjects with UC susceptible to disease restricted to the colon. Interestingly, we found a slightly higher correlation of pouch gene expression to colonic gene expression in patients with UC who went on to develop pouchitis (R 2 ¼ 0.8) (Fig. 3B ) than in those who remained healthy (R 2 ¼ 0.62) (Fig.  3A) . Thus, the degree to which the ileal pouch transcriptome resembles the colonic transcriptome may be an indicator of pouchitis risk, although the mechanisms underlying this shift are not understood.
Based on the correlation data in Figure 3A , B, we identified 46 genes that could serve as early-stage markers in the UC pouch for gain of colonic function (Quadrant 1 of Fig. 3A , B and Table 2) or loss of ileal function (Quadrant 3 of Fig. 3A , B and Table 3 ). All of the colonic and ileal markers identified in our cohort of patients with UC in the first 12 months of their pouch were also found to have concordant expression changes amongst the FIGURE 2. Canonical pathways associated with upregulated or downregulated genes in the UC pouch DEGs (fold change .1.5) in pouch versus prepouch ileum were submitted to Ingenuity Pathway Analysis software to identify significant pathways using one-tailed Fisher's exact test. The criterion of significance is Benjamini-Hochberg adjusted P , 0.01, i.e., 2log (adjusted P [adj.P]) . 2.0. A, Pathways associated with upregulated genes in pouch. B, Pathways associated with downregulated genes in pouch. The genes in these pathways can be found in Tables S2 or S3 patients with older pouches and active pouchitis in the study of Morgan et al 27 (Fig. 3C) . By contrast, only 19 genes demonstrated consistent direction of changes in Morgan's FAP pouch cohort and Comelli's healthy colon cohort compared to ileum, and the correlation of alterations was much lower (Fig. 3D , R 2 ¼ 0.435). We further validated 4 colonic biomarkers by quantitative reverse-transcription PCR on paired pouch and prepouch samples derived from an independent cohort of 13 patients with UC. Consistent with the RNA-seq data, CEACAM7, NXPE4, MUC4, and MUC1 displayed significant upregulation in the pouch as compared with the prepouch in the independent UC validation cohort (Fig. 4) .
Gain of colonic gene expression and loss of ileal gene expression were not found in the pouches of our patients with FAP because there were no significant DEGs between pouch and prepouch in FAP in our RNA-seq data. In addition, our reanalysis of microarray expression data 27 revealed that 76% (35/46) of these markers were differentially expressed (adjusted P , 0.05) between the ileal pouches of UC pouchitis and those of patients with FAP, whereas only 5/46 markers displayed differential expression (adjusted P , 0.05) between FAP pouch and prepouch ileum. Thus, we conclude that maturation of the UC ileal pouch involves transcriptomic remodeling with increased colonic transcript expression and decreased ileal transcript expression, and that many of these changes must be driven by some unique biological feature of the UC pouch environment.
We further estimated the colonic shift of the UC pouch transcriptome using published microarray data of global gene expression from the normal ileum, and ascending, descending, and sigmoid colon. 30 Differentially expressed UC pouch transcripts were examined for their expression levels along the intestine using SOM, which groups transcripts based on similarity of their regional expression pattern (Fig. 5) . Among transcripts upregulated in the UC pouch compared with prepouch, the largest gene cluster of regional expression (954 genes) displayed higher expression levels in the colon than the ileum (Fig. 5A , cluster highlighted with red *). Among transcripts downregulated in the pouch, the largest gene cluster showed decreased expression pattern along the colon versus ileum (Fig. 5B , cluster with 1065 genes highlighted with green #). Similar results were obtained using DEGs between pouch and prepouch from pouchitis microarray expression data 27 as the inputs for SOM analysis (Fig. 5C,  D) . However, SOM analysis of upregulated pouch genes in this FIGURE 3. The UC pouch transcriptome acquires colon-like features (A-C). Concordance of transcript ratios between pouch/prepouch ileum with normal colon/ileum. The expression data for healthy human colon and ileum transcriptomes were retrieved from Comelli et al. 29 
Each dot represents a single gene. A, Correlation plot of log2-transformed (colon/ileum) expression ratio with (pouch/prepouch ileum) ratio in patients with UC who did not develop pouchitis (UC-H). B, Correlation plot of log2-transformed (colon/ileum) expression ratio with (pouch/prepouch ileum) ratio in patients with UC who went on to develop pouchitis (UC-D). C, Correlation plot of log2-transformed (colon/ileum) expression ratio with
(pouch/prepouch ileum) ratio in patients with pouchitis with active disease .1 year after ileostomy closure from reanalysis of previously published microarray data set of Morgan et al. 27 D, Correlation plot of log2-transformed (colon/ileum) expression ratio with (pouch/prepouch ileum) ratio in patients with FAP from reanalysis of previously published microarray data set of Morgan et al. 27 Coefficients of determination are shown in each graph.
data set also revealed a large cluster of genes whose expression levels along the intestinal axis decreased from the ileum to colon (Fig. 5C , top right highlighted with green #). The appearance of this cluster may reflect a more complex reprogramming of the transcriptome influenced by active pouch inflammation. Overall, we take these findings as further confirmation that the UC pouch transcriptome gains colonic features and loses ileal features as it undergoes reprogramming after IPAA.
Transcripts in the largest SOM gene clusters in our UC pouch cohort ( Fig 5A, bottom right; and Fig. 5B , top right) were submitted to Ingenuity Pathway Analysis software to identify enriched canonical pathways and networks. Interestingly, the genes in both clusters were involved in "Cell Morphology, Cellular Assembly and Organization" (see Fig. S4 , Supplemental Digital Content 5, http://links.lww.com/IBD/B441).
Concordant Gene Expression Profiles Across Longitudinal Transcriptomic Assay
We identified 762 or 679 DEGs between UC pouch and prepouch ileum at 4 or 12 months post ileostomy closure, respectively, with criterion of adjusted P , 0.01 and fold change .1.5. The 374 upregulated or 388 downregulated genes at 12 months were used to generate gene expression heat maps for the pouch and prepouch ileum samples collected 4 months postoperatively (see Fig. S5 , Supplemental Digital Content 6, http:// links.lww.com/IBD/B442). Notably, all significantly upregulated or downregulated genes in the pouch over the prepouch ileum at 12 months were also consistently increased or decreased in the 4-month pouch over 4-month prepouch ileum, respectively. (see Fig. S5A or S5B, Supplemental Digital Content 6, http://links. lww.com/IBD/B442). Similarly, all of the 328 upregulated or 351 downregulated genes in 4-month pouch were also increased or decreased in the 12 month-pouch compared with 12-month prepouch ileum, respectively (see Fig. S6A or S6B, Supplemental Digital Content 7, http://links.lww.com/IBD/B443). These findings further confirmed that the transcriptomic alterations in UC pouch developed at a very early stage after ileostomy closure well before any changes in states of health and persisted. (Table 2) or ileal biomarkers (Table 3) were assembled from Quadrant-1 or Quadrant-3 genes, respectively, in Figure 3A , B. Adj. P. Val was computed using R/Bioconductor package "limma." Colonic biomarkers (Table 2 ) or ileal biomarkers (Table 3) were assembled from Quadrant-1 or Quadrant-3 genes, respectively, in Figure 3A , B. Adj. P. Val was computed using R/Bioconductor package limma. Pouch/prepouch in our RNA-seq data. Adj. P. Val, adjusted P-value; FC, fold changes.
Concordant Gene Expression Alterations in UC Pouch and in Inflamed UC
The 746 DEGs (378 upregulated and 368 downregulated genes) in UC pouch compared with prepouch ileum were mapped to the published microarray data set GSE10191 31 containing 8 inflamed UC colon and 15 healthy colon samples. 556/746 DEGs, including 237 upregulated and 319 downregulated genes in UC pouch could be mapped to the GSE10191 microarray platform. These genes were clustered based on their expression correlations in the GSE10191 data set (Fig. 6A, B) . Of the 237 upregulated pouch genes, 166 (70%) were higher in inflamed mucosa than in normal colon (Fig. 6A , blue subcluster of genes on left side). Similarly, 232/319 (73%) downregulated pouch genes were decreased during inflammation compared with the normal colon (Fig. 6B , blue subcluster of genes on the left side). Gene ontology analysis showed that the 166 mutually upregulated genes in earlystage pouch and inflamed UC were overrepresented in the biological processes involved in inflammatory response, extracellular matrix disassembly, cell matrix chemotaxis, and maintenance of gastrointestinal epithelium (see Table S4 , Supplemental Digital Content 3, http://links.lww.com/IBD/B439). The 232 mutually downregulated genes were overrepresented in xenobiotic metabolism, CYP450 pathway, polysaccharide digestion, sodium ion transport, vitamin K catabolism, and intestinal cholesterol absorption (see Table S5 , Supplemental Digital Content 3, http://links. lww.com/IBD/B439).
We also mapped the DEGs in our UC pouch to a microarray data set (GSE20881) with Crohn's disease and healthy controls. 32 The analysis did not show correspondence between gene expression profiles in Crohn's disease and in the UC pouch (see Fig. S7 , Supplemental Digital Content 8, http://links.lww.com/IBD/B444). These findings indicate that the pattern of transcriptomic alterations in the early stages of the pouch is consistent with that in active UC but not with Crohn's disease.
Enrichment Analysis of UC Colonic Crypt Genes for Pouch DEGs
To further investigate similarities between the early UC pouch transcriptome and gene expression patterns associated with active UC in the colon, we retrieved the 49 upregulated and 28 downregulated genes in UC colonic crypt compared with those of normal healthy colonic crypt from the microarray data published by Kim et al 33 (Fig. 5C ). Hypergeometric distribution testing revealed significant enrichment of the UC colonic crypt genes among pouch upregulated genes (P ¼ 2.1 · 10 24 , see Table S6 , Supplemental Digital Content 3, http://links.lww.com/ FIGURE 4. Quantitative reverse-transcription PCR validation of selected biomarkers on paired pouch and prepouch samples from an independent UC cohort. We validated 4 colonic biomarkers by quantitative reverse-transcription PCR on paired pouch and prepouch samples derived from an independent cohort of 13 patients with UC. The expression of each candidate gene was calculated relative to GAPDH. The P-value based on paired t-test is shown for the corresponding gene. Note that lower dCt value indicates higher expression value. dCt, delta cycle threshold; NXPE4, neurexophilin and PC-esterase domain family member 4.
IBD/B439). Notably, 79% (15/19) of the UC colonic crypt genes that displayed upregulation in our UC pouch were also upregulated in the active pouchitis pouch 27 (see Table S6 , Supplemental Digital Content 3, http://links.lww.com/IBD/B439). These findings highlight shared molecular features between UC ileal pouch and UC colonic crypt pathogenesis.
DISCUSSION
This study, the first longitudinal analysis of transcriptomic changes in the ileal pouch that occur during the first year after IPAA, provides several novel insights into the pathogenesis of UC pouchitis. In patients with UC, the pouch undergoes a unique shift in its global transcriptional program soon after functionalization. As a result of this transcriptomic reprogramming, many genes typically expressed in the colon become activated in the mucosa of the ileal pouch. At the same time, many ileum-associated transcripts also become less abundant. We showed that the colonic shift of transcriptome is a typical and dominant profile unique to the early stage of the UC pouch. This transcriptomic phenomenon occurs in the absence of detectable histological changes, showing that levels of specific RNAs are highly sensitive markers of tissue transformation. Many of the affected transcripts are found in pathways associated with inflammation and extracellular matrix remodeling. These changes are highly correlated with transcriptomic data from a recent cross-sectional study of patients with pouchitis 27 and also partially resemble the molecular pathogenesis of UC. 31, 33 The significant shifts that occur in the UC pouch transcriptome appear to provide unique insights into why this tissue becomes susceptible to the development of inflammation. Canonical pathways enriched for upregulated genes in the UC pouch included "IL17 signaling," "Communication between Innate and Adaptive Immune Cells," "Primary Immunodeficiency Signaling and Acute Phase Response Signaling" (see Table S2 , Supplemental Digital Content 3, http://links.lww.com/IBD/B439). This analysis supports proposed roles for aberrant immune function in pouchitis etiology. 4, 34, 35 Downregulated genes in the UC pouch are enriched for multiple lipid metabolism and signaling pathways, including "LXR/RXR activation" and "FXR/RXR activation" (see Tables S2 and S3 , Supplemental Digital Content 3, http://links.lww.com/IBD/B439). LXR/RXR activation is involved in the regulation of lipid metabolism, inflammation, FIGURE 5 . SOM clustering of pouch DEGs along the proximal-distal axis of normal intestine. DEGs between the pouch and prepouch ileum in our UC cohort (A-B) and from Morgan et al 27 (C-D) were mapped to published microarray expression data for normal human ileum and ascending, descending, and sigmoid colon. 30 The mapped upregulated or downregulated genes in the pouch were partitioned into 3 · 3 SOM clusters. Location within the intestine 30 is shown on the x-axis. Gene expression levels were standardized with mean of 0 and variance of 1, and shown on the y-axis. The number of upregulated or downregulated genes in the pouch whose expression pattern along the normal intestine matches the given pattern is shown at the top of each box. * or # indicates the largest incline or decline gene cluster in the corresponding SOM and thus represents the major pattern of gene expression levels along the normal intestine. Ile, ileum; Asc, ascending colon; Des, descending colon; and Sig, sigmoid colon. and cholesterol to bile acid catabolism. 36 Activation of LXRs strongly suppresses the expression of inflammatory mediators, such as tumor necrosis factor alpha. 37 FXR/RXR activation plays a crucial role in linking bile acid regulation with lipoprotein, lipid, and glucose metabolism. 38 Nicotine suppresses the production of proinflammatory cytokines, attenuates inflammation, and improves gut function in patients with active colitis. 39 Other studies have also suggested that active smokers have fewer episodes of UC pouchitis after proctocolectomy. 40 Consistent with this notion, our findings of the suppression of nicotine degradation pathway in the ileal pouch (Fig. 2B ) may be relevant and underlie the interesting epidemiological relationship between UC and smoking. 41 Finally, altered mucosal barrier function might serve as an additional contributor to disease susceptibility given that 39 genes encoding tight junction components are differentially expressed between the UC pouch and prepouch ileum in both of our RNA-seq UC cohort and Morgan's microarray pouchitis cohort (see Fig. S3 , Supplemental Digital Content 4, http://links.lww. com/IBD/B440). In summary, our functional pathway analysis uncovered several molecular mechanisms present in early-stage pouch tissues that may promote the development of pouchitis.
The colon-like shift that the ileal tissue undergoes after IPAA may increase disease susceptibility. The colonic biomarker CEACAM-7 was among the most highly upregulated genes in the UC pouch in this study and also in the previous study of Morgan et al. 27 Moreover, CEACAM-7 was previously known to be overexpressed in the histologically normal crypts microdissected from formalin-fixed biopsies of early-stage UC before active inflammation is initiated, suggesting that this gene is relevant to the pathogenesis of UC (see Table S6 , Supplemental Digital Content 3, http://links.lww.com/IBD/B439). 33 CEACAM7 is part of an immunoglobulin superfamily of genes that have numerous functions including cell adhesion and signaling. 42 Like other members of the family, CEACAM-7 is glycosylphosphatidylinisotol linked and is sorted to the apical membrane in the epithelium. However, very little is known about its functions, except it lacks a cytoplasmic tail that usually is needed for cell signaling. 42 has been proposed to modify the function of other CEACAM isoforms through protein-protein interactions. 43 Its upregulation in the ileal pouch as colonic biomarker and in the colonic crypt epithelia of early-stage UC illustrates mutual molecular pathogenesis for pouchitis and UC.
We hypothesize that the gene expression changes that render previously normal ileal tissue susceptible to the possible development of pouchitis may resemble the original disease promoting gene expression changes in UC. The expression of matrix metalloproteinases (MMPs) in the ileal pouch shares characteristics with inflamed IBD tissues. 44 MMP1, MMP2, and MMP3 are increased in both pouchitis and UC. [45] [46] [47] [48] [49] Degradation of extracellular matrix and tissue remodeling are achieved through the concerted action of diverse extracellular proteases. Among these, MMPs and their physiological counterparts, tissue inhibitors of metalloproteinases are of central importance. 50 MMPs are involved in mucosal destruction and crypt hyperplasia in FIGURE 6 . Concordant transcriptome alterations in the UC pouch and UC colon. Upregulated (A) and downregulated (B) genes in the UC pouch were mapped to the published UC colon microarray data set GSE10191, 31 which contains 8 inflamed UC and 15 normal colon biopsy samples. Hierarchical clustering of the mapped genes was based on their correlation across all samples in GSE10191, as shown on the left dendrogram of the heatmap. Note that 70% of the upregulated genes or 73% of the downregulated genes in pouches were also increased or decreased in inflamed UC colons in (A) or (B) (blue highlighted dendrogram), respectively. Relative expression levels for each gene are indicated by color (black, mean level across all samples; green, below the mean; and red, above the mean). C, 49 upregulated and 28 downregulated genes in UC colonic crypts compared with normal colonic crypts were retrieved from the microarray study by Kim et al. 33 The 77 genes were mapped to the upregulated or downregulated genes in the UC pouch. Red or green bar color denotes upregulated or downregulated genes in the UC colonic crypt, respectively. Significant overlap of upregulated (or downregulated) genes between UC colonic crypts and UC pouches was determined using hypergeometric distribution; P-value shown in the corresponding section of each bar.
pouchitis. 45 Our pathway analysis of transcriptomic profile in early-stage pouch revealed an increased tissue remodeling activity associated with upregulation of MMP1, MMP3, MMP10, MMP12, and tissue inhibitors of metalloproteinases-1 (see Table S2 , Supplemental Digital Content 3, http://links.lww.com/ IBD/B439). These findings point to shared transcriptional regulation for extracellular matrix remodeling as a key feature of pathogenesis in both pouchitis and UC. Importantly, the patients in this study were sampled before the onset of any disease. Thus, the similarity in gene expression between the noninflamed ileal pouch and actively inflamed UC tissue suggests that these ileal pouch gene expression changes may be a precondition for the development of inflammation triggered by other environmental (possibly microbial) factors. In this regard, our group recently reported the presence of unique Bacteroides capsular polysaccharide adaptations between luminal and mucosal strains within different UC pouches. Based on the known virulence potential of capsular polysaccharide genes to stimulate, suppress, and/or evade hostspecific immune and epithelial responses, we speculate that genetic elements transferred horizontally may impart to microbial strains the ability to become causative agents of disease on a background of host genetic susceptibility. 51 Although this study provides important insights into the molecular processes associated with early-stage pouch progression, there are some limitations. Our patient cohort was relatively small especially with respect to patients with FAP. As a result, a gender bias was observed in our UC cohort in that more female patients developed pouchitis (x 2 test P ¼ 0.0133). This is in concordance with a published report about an increased risk for the development of pouchitis in female patients. 3 Although the gender bias cannot be fully avoided in prospective enrollment of patients, a larger cohort of patients could help minimize such bias. Because the FAP sample size is small in our current RNA-seq study, we performed a meta-analysis to validate the larger effect size of the pouch in our RNA-seq UC cohort as compared with Morgan's larger microarray analyzed FAP cohort. (see Fig. S2B , Supplemental Digital Content 2, http://links.lww.com/IBD/B438). Because of the early time points chosen for this study and the small numbers of patients, distinguishing the noted gene expression changes by pouchitis phenotype was not possible in this study. However, future studies that follow patients for a longer time period may be better able to characterize patients refractory to antibiotic treatment that may more closely resemble patients with UC.
Our data provide new insights into why the previously normal ileal tissue of patients with UC becomes susceptible to the development of inflammation after creation of an ileal pouch. Furthermore, patients with FAP rarely develop pouchitis despite undergoing the same procedure. We propose that the unique shift toward a colon-like transcriptome in the pouch of the UC patient (Figs. 3 and 5 ) renders the mucosa susceptible to UCrelated processes that potentiate the development of inflammation. Moreover, a large set of upregulated or downregulated genes (Fig. 6) , and activated or suppressed biological processes are shared between early-stage ileal pouch and inflamed UC (see Tables S4 and S5 , Supplemental Digital Content 3, http://links. lww.com/IBD/B439). Given that both patients who did and did not develop pouchitis exhibited ileal pouch gene expression changes as compared with the prepouch ileum, these changes likely set the preconditions for inflammation, and other environmental factors are likely needed to ultimately trigger inflammation. The onset of disease likely requires an interaction between the proinflammatory pouch tissue and other yet unknown factors, including the pouch microbiota. 52 
